Andere Kunden interessierten sich auch für
![Role of MicroRNA-16 & 21 in Breast Cancer Patients and their Daughters]( "Role of MicroRNA-16 & 21 in Breast Cancer Patients and their Daughters")
Role of MicroRNA-16 & 21 in Breast Cancer Patients and their Daughters29,99 €![Serum Neopterin Level In Early Onset Neonatal Sepsis]( "Serum Neopterin Level In Early Onset Neonatal Sepsis")
Serum Neopterin Level In Early Onset Neonatal Sepsis36,99 €![Association of Maternal Serum C-reactive protein level with Gestational Diabetes Mellitus]( "Association of Maternal Serum C-reactive protein level with Gestational Diabetes Mellitus")
Association of Maternal Serum C-reactive protein level with Gestational Diabetes Mellitus29,99 €![Ruolo dei microRNA-16 e 21 nelle pazienti affette da cancro al seno e nelle loro figlie]( "Ruolo dei microRNA-16 e 21 nelle pazienti affette da cancro al seno e nelle loro figlie")
Ruolo dei microRNA-16 e 21 nelle pazienti affette da cancro al seno e nelle loro figlie29,99 €![Papel do MicroRNA-16 & 21 nos doentes com cancro da mama e suas filhas]( "Papel do MicroRNA-16 & 21 nos doentes com cancro da mama e suas filhas")
Papel do MicroRNA-16 & 21 nos doentes com cancro da mama e suas filhas29,99 €![Die Rolle von MicroRNA-16 & 21 bei Brustkrebspatientinnen und ihren Töchtern]( "Die Rolle von MicroRNA-16 & 21 bei Brustkrebspatientinnen und ihren Töchtern")
Die Rolle von MicroRNA-16 & 21 bei Brustkrebspatientinnen und ihren Töchtern43,90 €![Breast cancer classification, serum adiponectin and SNP rs 2241766]( "Breast cancer classification, serum adiponectin and SNP rs 2241766")
Breast cancer classification, serum adiponectin and SNP rs 224176640,99 €
Breast cancer is a global public health burden. The stage at diagnosis is an important predictor of patient outcome. Thus there is an urgent need for developing more robust biomarkers. The discovery of circulating microRNAs along with their important role in cancer initiation and progression highlights their potential use as a non-invasive biomarker for cancer detection, evaluation, and follow-up. MicroRNA-21, in particular, has attracted a great deal of attention, since it is one of the most highly up-regulated microRNAs in many cancers. Herein, serum microRNA-21 levels were assessed in breast cancer patients, asymptomatic high-risk individuals and healthy individuals. In addition, expression levels of microRNA-21 in patients were re-evaluated after curative tumor resection. Current results could have crucial clinical applications in screening, diagnosis, and monitoring of this devastating disease.